The in vivo role of Rev1 in mutagenesis and carcinogenesis
Abstract Translesion synthesis (TLS) is an error-prone pathway required to overcome replication blockage by DNA damage. Aberrant activation of TLS has been suggested to play a role in tumorigenesis by promoting genetic mutations. However, the precise molecular mechanisms underlying TLS-mediated tumo...
Main Authors: | Megumi Sasatani, Elena Karamfilova Zaharieva, Kenji Kamiya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Genes and Environment |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41021-020-0148-1 |
Similar Items
-
REV1 Inhibition Enhances Radioresistance and Autophagy
by: Kanayo E. Ikeh, et al.
Published: (2021-10-01) -
REV1: A novel biomarker and potential therapeutic target for various cancers
by: Ning Zhu, et al.
Published: (2022-09-01) -
The Catalytic Activity of Human REV1 on Undamaged and Damaged DNA
by: Anastasia D. Stolyarenko, et al.
Published: (2024-04-01) -
Protein–Protein Interactions in Translesion Synthesis
by: Radha Charan Dash, et al.
Published: (2021-09-01) -
HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective
by: Jason W. Rausch, et al.
Published: (2015-06-01)